BNTC

Benitec Biopharma Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-09-14

Figures on this page computed 2026-11-08 12:56 UTC

Last close

9.54USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2026, filed 2026-09-14

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Ten years as a story

lens 9 of 9
2016-09-30 to 2026-11-069.54
Its closing price: 357.00 on 2016-09-30 to 9.54 on 2026-11-06, down 97%.

Every filing we hold, oldest first

8
  1. 2020-09-23Annual report for 201910-K
  2. 2020-09-23Annual report for 202010-K
  3. 2021-09-20Annual report for 202110-K
  4. 2022-09-02Annual report for 202210-K
  5. 2023-09-21Annual report for 202310-K
  6. 2024-09-26Annual report for 202410-K
  7. 2025-09-22Annual report for 202510-K
  8. 2026-09-14Annual report for 202610-K

8 filings over the years we hold, each pinned to the day it landed.

8 filings over the years we hold, each pinned to the day it landed.

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.